AFP - The US Supreme Court has shaken up the standard for patents in rulings that could have far-reaching implications for the technology sector, but also other industries such as pharmaceuticals.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
